EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Catenibacterium mitsuokai with icariin modulates gut microbiota and improves hepatic lipid metabolism in intrauterine growth restriction

Yusen Wei, Jiangdi Mao, Wenjie Tang, Yanfei Ma, Jiachen Li, Songtao Su, Zhixiang Ni, Jinhong Wu, Daren Liu, Haifeng Wang iD

The ISME Journal · 02.01.2025 · 19 (1)

DOI: 10.1093/ismejo/wraf141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The ISME Journal, online erschienen am 03.07.2025. Verfasst von Yusen Wei und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Molecular Animal Nutrition, Ministry of Education, College of Animal Science, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Fetal Growth Retardation, Lipid Metabolism, Flavonoids. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Key R&D Projects of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Male offspring with intrauterine growth restriction (IUGR) exhibit more pronounced hepatic lipid metabolism abnormalities than females, necessitating earlier intervention. Icariin (ICA) has been shown to effectively modulate hepatic lipid metabolism in male piglets with IUGR. However, the role of gut microbiota in this process remains to be elucidated. This study aimed to explore the influence of gut microbiota on ICA-induced enhancement of hepatic lipid metabolism. By examining changes in microbiota composition and hepatic lipid metabolism following ICA intervention, the study demonstrated an association between microbial alterations and hepatic lipid regulation through fecal microbiota transplantation. The impact of Catenibacterium on gut microbiota structure and hepatic lipid metabolism was assessed in vivo, and the direct effect of ICA on Catenibacterium was explored in vitro. Results revealed that ICA intervention modified fecal, ileal, and colonic microbiota in male piglets with IUGR, enhanced gut morphology and barrier function, and normalized the expression of hepatic peroxisome proliferator-activated receptor signaling pathway-related genes. Fecal microbiota transplantation from piglets with IUGR impaired intestinal barrier function and led to hepatic lipid deposition, whereas transplantation from ICA-treated donors showed no pathological changes, an outcome associated with reduced abundance of Catenibacterium. Mechanistically, ICA inhibits adenosine triphosphate synthesis to suppress Catenibacterium, remodels gut microbiota, reduces lipopolysaccharide production and translocation, and activates the hepatic PPARα/CD36 axis. In conclusion, ICA intervention alleviates hepatic lipid metabolic disorders in male offspring with IUGR by suppressing Catenibacterium, restoring gut microbial balance, and enhancing intestinal barrier integrity to limit lipopolysaccharide translocation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeFetal Growth RetardationLipid MetabolismFlavonoidsLiverAnimalsMaleSwineFecal Microbiota TransplantationFemaleFeces

Stichwörter der Autor:innen

CatenibacteriumIUGRicariinlipid metabolismmicrobiotapiglet

Substanzen

Flavonoidsicariin

Autor:innen und Institutionen

  • The Key Laboratory of Molecular Animal Nutrition, Ministry of Education, College of Animal Science, Zhejiang University, Hangzhou 310058, China.
  • The Second Affiliated Hospital of Zhejiang University, Department of Hepatobiliary and Pancreatic Surgery, Hangzhou 310009, China.

ORCID-Profile: Haifeng Wang

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Key R&D Projects of Zhejiang Province

Zitieren

APA

Wei, Y., Mao, J., Tang, W., Ma, Y., Li, J., Su, S., Ni, Z., Wu, J., Liu, D., & Wang, H. (2025). Targeting Catenibacterium mitsuokai with icariin modulates gut microbiota and improves hepatic lipid metabolism in intrauterine growth restriction. The ISME Journal, 19(1). https://doi.org/10.1093/ismejo/wraf141

Vancouver

Wei Y, Mao J, Tang W, Ma Y, Li J, Su S, et al. Targeting Catenibacterium mitsuokai with icariin modulates gut microbiota and improves hepatic lipid metabolism in intrauterine growth restriction. The ISME Journal. 2025;19(1). doi:10.1093/ismejo/wraf141

BibTeX
@article{Wei2025,
  author = {Wei, Yusen and Mao, Jiangdi and Tang, Wenjie and Ma, Yanfei and Li, Jiachen and Su, Songtao and Ni, Zhixiang and Wu, Jinhong and Liu, Daren and Wang, Haifeng},
  title = {Targeting Catenibacterium mitsuokai with icariin modulates gut microbiota and improves hepatic lipid metabolism in intrauterine growth restriction},
  journal = {The ISME Journal},
  year = {2025},
  volume = {19},
  number = {1},
  doi = {10.1093/ismejo/wraf141}
}
Kostenlos starten →